3 Comments

CHAPTER 87 LYMPHOCYTOSIS AND LYMPHOCYTOPENIA

CHAPTER 87 LYMPHOCYTOSIS AND LYMPHOCYTOPENIA
Williams Hematology

CHAPTER 87 LYMPHOCYTOSIS AND LYMPHOCYTOPENIA

THOMAS J. KIPPS

Lymphocytosis

Definition

Primary Lymphocytosis

Secondary (Reactive) Lymphocytosis
Lymphocytopenia

Definition

Inherited Causes

Acquired Lymphocytopenia

Idiopathic CD4+ T Lymphocytopenia
Chapter References

The causes of lymphocytosis or lymphocytopenia are many and varied. This chapter outlines the conditions associated with abnormalities in the numbers of circulating lymphocytes in the blood. It also serves as a useful road map to other chapters in the book that describe in detail those conditions that commonly are associated with abnormalities in the absolute numbers of circulating lymphocytes.

Acronyms and abbreviations that appear in this chapter include: EBV, Epstein-Barr virus; NK, natural killer; PPBL, persistent polyclonal lymphocytosis of the B lymphocytes; PUVA, psoralen and ultraviolet A irradiation.

LYMPHOCYTOSIS
DEFINITION
Lymphocytosis is defined as an absolute lymphocyte count exceeding 4 × 109/liter (4000/µl),1 although somewhat lower threshold values (>3.1 × 109/liter (>3100/µl)) are sometimes used.2 The normal absolute lymphocyte count is significantly higher in childhood. The methods for determining the absolute lymphocyte count and the normal range for such counts are described in Chap. 2.
The blood film of patients with lymphocytosis should be evaluated for a predominance of reactive lymphocytes associated with infectious mononucleosis (see Chap. 90), large granular lymphocytes associated with large granular lymphocytic leukemia (see Chap. 100), smudge cells associated with chronic lymphocytic leukemia (see Chap. 98), or blasts of acute lymphocytic leukemia (see Chap. 97). A description of normal lymphocyte morphology is provided in Chap. 80.
Characterization of cell surface markers is valuable in distinguishing primary lymphocytosis (leukemic) from secondary lymphocytosis (reactive). New improvements in flow cytometry techniques and reagents have allowed clinical laboratories to perform flow cytometric immunophenotyping to distinguish benign from neoplastic lymphoproliferative disease (see Chap. 13).3,4,5,6,7,8,9,10 and 11 Analysis for immunoglobulin or T-cell receptor gene rearrangement also may provide evidence for monoclonal B-cell or T-cell proliferation, respectively.12
PRIMARY LYMPHOCYTOSIS
Primary lymphocytosis defines conditions associated with an increase in the absolute number of lymphocytes secondary to an intrinsic defect in the expanded lymphocyte population (Table 87-1). These conditions also are referred to as lymphoproliferative disorders and most commonly are secondary to the neoplastic accumulation of monoclonal B cells, T cells, natural killer (NK) cells, or less fully differentiated cells of the lymphoid lineage. The chapters describing each of these conditions are indicated in Table 87-1.

TABLE 87-1 CAUSES OF LYMPHOCYTOSIS

Although patients with lymphocytosis secondary to lymphoproliferative disease generally maintain abnormal lymphocyte counts that may rise over time,13 this is not invariable. Patients with large granular lymphocytic leukemia (see Chap. 100) may have only transient lymphocytosis that is induced by stress or exercise.14
MONOCLONAL B-CELL LYMPHOCYTOSIS
The advent of flow cytometric and molecular diagnostic techniques has identified a syndrome in patients who have expanded populations of monoclonal B cells without other associated clinical signs or symptoms.15,16,17 and 18 This syndrome may resemble that of patients with essential monoclonal gammopathy who otherwise do not have the clinical features of myeloma. Such patients also were identified after improved technology was introduced for evaluating serum immunoglobulins (see Chap. 104 and Chap. 105). Similar to the latter, some patients who have expanded populations of monoclonal B cells may develop progressive neoplastic lymphoproliferative disease.19
PERSISTENT POLYCLONAL LYMPHOCYTOSIS OF B LYMPHOCYTES
Lymphocytosis can be secondary to an expansion in the numbers of B cells that are “polyclonal” in their expression of immunoglobulin. Patients with this disorder, termed persistent polyclonal lymphocytosis of B lymphocytes (PPBL), each have increased numbers of kappa and lambda light-expressing B cells that are heterogeneous in their rearrangements of immunoglobulin heavy-chain genes.20,21 and 22 Occasional reports of clonal immunoglobulin rearrangements in this disorder suggest that the polyclonal expansion in some cases may be followed by the emergence of one predominant clone.23,24
The cause or causes of PPBL are unknown. Epstein-Barr virus (EBV) genomes have been detected in blood lymphocytes of patients with this disorder.25,26 and 27 One study found a 69 base-pair deletion variant of the gene encoding the EBV latent membrane protein 1 in the lymphocytes of a PPBL patient but not in the lymphocytes of unaffected siblings, suggesting a role for altered LMP1 in the pathogenesis of PPBL.28 Gender and genotype also may be important in the pathogenesis, since the patients most commonly are young to middle-aged women who often are HLA-DR7 positive.24 In addition, there are reports of shared cases of PPBL among identical twins,29 suggesting a possible hereditary or genetic contribution to the pathogenesis. However, the causes of this abnormality may be heterogeneous, as PPBL may not be a single disease entity.
Patients with PPBL can have features that resemble those of patients with various monoclonal B-cell malignancies. In one manifestation of this syndrome, first identified in Japan as hairy B-cell lymphoproliferative disorder,30 the patients can present with anemia, thrombocytopenia, and splenomegaly, and have an excess of polyclonal B lymphocytes that appear similar in morphology to the neoplastic B cells in hairy-cell leukemia. In another manifestation of this syndrome, the patients have an accumulation of polyclonal B cells that coexpress CD19, CD5, and CD23, thus displaying an immunophenotype similar to that of B-cell chronic lymphocytic leukemia.31,32
In perhaps the most common manifestation of PPBL, however, the patients have an accumulation of polyclonal B cells that have an unusual binucleate appearance on the blood film.21,24,33 These patients often have mild splenomegaly and raised serum IgM levels. This disorder appears more common among cigarette smokers20,23,34 and most typically is associated the HLA-DR7 haplotype.24
Although the lymphocytosis of PPBL generally is not progressive, most patients will have small numbers of blood B cells that have chromosomal abnormalities. These most commonly include an additional isochromosome +i(3q) and premature chromosome condensation,21,35 although t(14;18) involving the BCL-2 and the immunoglobulin heavy chain loci also have been detected.22,36,37 In any one patient, these chromosomal abnormalities are restricted to B lymphocytes independent of their expression of immunoglobulin kappa or lambda light chain.21 For PPBL associated with smoking, these cytogenetic abnormalities apparently persist after the discontinuation of tobacco use.24 The finding of such chromosome abnormalities is consistent with the notion that PPBL may represent a preneoplastic state. Consistent with this, a small proportion of patients with PPBL ultimately will develop monoclonal B-cell lymphoma or B-cell leukemia.38,39
SECONDARY (REACTIVE) LYMPHOCYTOSIS
Secondary lymphocytosis defines conditions associated with an increase in the absolute number of lymphocytes secondary to a physiologic or pathophysiologic response to infection, toxins, cytokines, or unknown factors.40
INFECTIOUS MONONUCLEOSIS
The most common reactive lymphocytosis is infectious mononucleosis (see Table 87-1). This syndrome is described in Chap. 90.
ACUTE INFECTION LYMPHOCYTOSIS
A disorder possibly related to infectious mononucleosis is acute infection lymphocytosis, a contagious disease that is characterized by an increase in circulating lymphocytes, often to 20 to 30 × 109/liter (20,000 to 30,000/µl)41 and occasionally to 100 × 109/liter (100,000/µl).42 The patients are usually asymptomatic but may have fever, abdominal pain, or diarrhea. Lymph node enlargement and splenomegaly do not occur, and the patient’s serum usually is negative for heterophil antibodies. In this regard, the disease resembles infectious mononucleosis caused by viruses other than EBV, such as cytomegalovirus (see Chap. 90).43,44,45 and 46 In some cases, the lymphocytosis has been found in association with acute infection by coxsackievirus B2.47 Clinical symptoms last for a few days, but the lymphocytosis may persist for several weeks. Eosinophilia may be present. The marrow has been examined in a few patients and has shown minimal increases in lymphocytes, but marked infiltration with lymphocytes has also been observed.
Toxoplasmosis also can present with reactive lymphocytosis in the absence of lymphadenopathy, especially in the immune-compromised host.48 Lymphocytosis with atypical lymphocytes also can be part of the early manifestation of acute infection with Falciparum malaria.49
BORDETELLA PERTUSSIS
A marked increase in the number of morphologically normal lymphocytes occurs in patients infected with the gram-negative bacterium Bordetella pertussis. Absolute lymphocyte counts range from 8 to 70 × 109/liter (8,000 to 70,000/µl), with a mean of approximately 30 × 109/liter (30,000/µl).50 The lymphocytes are predominantly CD4+ T cells.51,52
The lymphocytosis primarily results from the failure of lymphocytes to leave the blood because of a toxin, termed pertussis toxin, released by the bacteria.53 Pertussis toxin is an ADP-ribosylase that modifies Gi proteins in mammalian lymphocytes and inhibits their capacity to traffic from blood into lymphoid tissues, primarily through the inhibition of chemokine receptors.54,55 Pertussis toxin also may stimulate egress of maturing T cells from the thymus52,56 and may bind to neuraminic acid residues of T-cell–surface glycoproteins to induce T-cell activation.57
STRESS LYMPHOCYTOSIS
Trauma, surgery, acute cardiac failure, septic shock, myocardial infarction, sickle cell crisis, or status epilepticus may be associated with an elevated lymphocyte count, often above 5 × 109/liter (5000/µl),58,59 which may revert to normal or below-normal levels within hours.2 The increased lymphocyte count appears promptly after the event and appears secondary to lymphocyte redistribution.60 A transient lymphocytosis can be induced by the adrenaline released and/or administered in response to the medical episode.61,62 and 63 Characteristically, two phases are recognized after catecholamine administration: a quick (<30 min) mobilization of lymphocytes, followed by an increase in granulocyte numbers with decreasing lymphocyte numbers.63
POSTSPLENECTOMY LYMPHOCYTOSIS
Patients undergoing splenectomy for staging of Hodgkin’s disease may develop a chronic postoperative polyclonal lymphocytosis.64 An absolute lymphocyte count ranging from 4.0 to 8.7 × 109/liter often is noted 4 to 242 (median 70) months after splenectomy and can persist for prolonged periods (e.g., >50 months).65
PERSISTENT LYMPHOCYTOSIS
Patients may have subacute or chronic lymphocytosis, termed persistent lymphocytosis, in association with a variety of clinical situations (see Table 87-1).
Autoimmune Disease Patients with rheumatoid arthritis and related disorders may have lymphocytosis secondary to increased numbers of large granular lymphocytes.66 Occurring in less than 0.6 percent of patients with rheumatoid arthritis, large granular lymphocytic lymphocytosis almost invariably is associated with neutropenia in the absence of splenomegaly and thus may represent a subset disorder of patients with Felty syndrome.66,67 Patients with autoimmune pure red-cell aplasia or immune thrombocytopenia also may have expanded numbers of polyclonal T cells68 or NK cells.69
Cancer Patients with lymphocytosis may be found to have underlying neoplastic disease.70 Most notably, patients with malignant thymoma may have a polyclonal T-cell lymphocytosis thought to be secondary to the aberrant release of thymic hormones by the neoplastic thymic epithelium.71,72,73,74 and 75 A reactive lymphocytosis or plasmacytosis may be detected in up to 7 percent of patients with acute myeloid leukemia.76
Chronic Inflammatory Diseases Persistent lymphocytosis has been reported in patients with systemic diseases associated with inflammation.70,77 It has been noted in patients with sarcoidosis78 or Wegener granulomatosis.70
Cigarette Smoking Cigarette smokers may have a persistent lymphocytosis secondary to an increase in polyclonal CD4+ T cells and B cells, some of which have an unusual binuclear morphology.20,34,79
Hypersensitivity Reactions Delayed hypersensitivity reactions to insect bites may be associated with a large granular lymphocytic lymphocytosis and adenopathy.80 Idiosyncratic drug reactions also may be associated with subacute lymphocytosis.81
LYMPHOCYTOPENIA
DEFINITION
The methods for determining the absolute lymphocyte count and the normal range for such counts are presented in Chap. 2. Lymphocytopenia is defined as a total lymphocyte count of less than 1.0 × 109/liter (1,000/µl),100 but some consider the lower limit of normal to be 1.5 × 109/liter (1500/µl).101 Because approximately 80 percent of normal adult blood lymphocytes are T lymphocytes and nearly two-thirds of blood T lymphocytes are CD4+ (helper) T lymphocytes, most patients noted to have lymphocytopenia have reductions in the absolute numbers of T lymphocytes, particularly CD4+ T lymphocytes. The average absolute number of T lymphocytes in normal adult blood is 1.9 × 109/liter (1900/µl), ranging from 1.0 to 2.3 × 109/liter (1000 to 2300/µl).102 The average absolute number of CD4+ T lymphocytes is 1.1 × 109/liter (1100/µl), ranging from 7.2 to 14 × 108/liter (720 to 1400/µl). The average absolute number of cells of the other major T-cell subgroup, CD8+ T lymphocytes, is 6.5 × 108/liter (650/µl), ranging from 3.8 to 9.7 × 108/liter (380 to 970/µl). Some Asians and blacks may lack or be heterozygous for an epitope on the CD4 molecule that is recognized by the mouse monoclonal antibody OKT4A, thus making these patients appear to have a deficiency in the absolute number of CD4 T cells. The use of other anti-CD4 monoclonal antibodies (e.g., Leu-3a) that bind other epitopes of the CD4 molecule may help rule out factitious CD4+ T-cell depletion.
Table 87-2 summarizes the conditions associated with lymphocytopenia. The mechanism of lymphocytopenia is not established for many of these disorders, and several possible mechanisms exist. Further discussion of lymphocytes and of the diseases associated with lymphocytopenia are presented in the cited reports (see Table 87-2).

TABLE 87-2 CAUSES OF LYMPHOCYTOPENIA

The relative incidence of each of these conditions will vary, depending upon the patient population. In one New Zealand survey of patients who had significant lymphocytopenia (<0.6 × 109/liter), the patients fell into several categories with some overlap.103 In order of decreasing frequency, the factors associated with lymphocytopenia were bacterial or fungal sepsis (250 patients), major surgery (228 patients), definite (153 patients) or suspected (53 patients) corticosteroid therapy, malignancy (180 patients), cytotoxic therapy and/or radiotherapy (90 patients), recent trauma or hemorrhage (86 patients), renal allograft (38 patients), marrow allograft (35 patients), “viral infections” other than human immunodeficiency virus (HIV; 26 patients), or infection with HIV (13 patients). Only one patient was suspected of having idiopathic CD4+ T lymphocytopenia.
INHERITED CAUSES
Patients with inherited immunodeficiency diseases may have associated lymphocytopenia (Table 87-2) (see Chap. 88). Inherited immunodeficiency disorders may have a quantitative or qualitative stem cell abnormality, resulting in ineffective lymphopoiesis (see cited references in Table 87-2). Others, such as the Wiskott-Aldrich syndrome, have associated lymphopenia due to premature destruction of T cells secondary to a defect in the lymphocyte cytoskeleton.104
ACQUIRED LYMPHOCYTOPENIA
Acquired lymphocytopenia defines syndromes associated with depletion of blood lymphocytes that are not secondary to inherited disease.
INFECTIOUS DISEASES
The most common infectious disease associated with lymphopenia is the acquired immunodeficiency syndrome. The lymphocytopenia is due in part to destruction and/or clearance of CD4+ T cells infected with HIV-1 or HIV-2.102,105,106,107,108 and 109 The lymphocytopenia also may reflect impaired lymphocyte production and proliferation secondary to loss of the normal thymic or lymphoid architecture and the high levels of transforming growth factor b that often are noted in patients with this disease (see Chap. 89).
Other viral and bacterial diseases may be associated with lymphocytopenia (see Table 87-2). Patients presenting with active tuberculosis often have lymphocytopenia that usually resolves 2 weeks after initiating appropriate antimicrobial therapy.110 In acute viral infection, the lymphocytes may be destroyed by the infection, may be trapped in the spleen or nodes, or may migrate to the respiratory tract.106,111
IATROGENIC
Radiotherapy, neoplastic chemotherapy, glucocorticoids, and the administration of antilymphocyte globulin all lead to lymphocytopenia by destroying circulating lymphocytes.103,112,113,114,115 and 116 Long-term treatment of psoriasis with psoralen and ultraviolet A irradiation (PUVA) may result in T-lymphocyte lymphopenia, possibly through destruction of cells circulating through the cutaneous vasculature.117 The mechanism by which glucocorticoids cause lymphocytopenia is not clear but may be secondary to a glucocorticoid-induced redistribution of lymphocytes118,119 in addition to an induced cell destruction.112,119,120 Redistribution also may be responsible for the lymphocytopenia occurring after surgery.121,122 and 123 In thoracic duct drainage, the lymphocytes are lost from the body.124 Platelet apheresis similarly lowers the lymphocyte count because of an inadvertent removal of lymphocytes with the platelets.125
SYSTEMIC DISEASE ASSOCIATED WITH LYMPHOCYTOPENIA
Patients with systemic autoimmune disease can have lymphocytopenia, either secondary to the underlying disease or to therapy.126 The lymphocytopenia of patients with systemic lupus erythematosus may be autoantibody mediated.127,128 The lymphocytopenia of sarcoidosis and renal failure may be due to impaired T-lymphocyte proliferative responses.129,130 In conditions such as protein-losing enteropathy, lymphocytes may be lost from the body.131 Severe thermal injury may result in profound T-cell lymphopenia secondary to redistribution of blood T cells to the tissues.132
NUTRITIONAL OR DIETARY
Zinc is essential for normal T-cell development and function.133 Zinc therapy corrects the lymphocytopenia of zinc deficiency, and lymphocytic function also is restored. Excessive intake of ethanol and/or chronic ethanol use may impair lymphocyte proliferative responses. The associated lymphopenia may resolve with abstinence from alcohol.134
IDIOPATHIC CD4+ T LYMPHOCYTOPENIA
The advent of immunophenotyping and HIV serologic testing has identified a syndrome of isolated CD4+ T-cell depletion in the absence of evidence for retroviral infection. The syndrome, termed idiopathic CD4+ T lymphocytopenia by the Centers for Disease Control and Prevention in 1993, is defined by a CD4+ T-lymphocyte count of less than 3 × 108/liter (300/µl) on two separate occasions in patients without serologic or virologic evidence of HIV-1 or HIV-2 infection.135 It is important to exclude congenital immunodeficiency diseases, such as common variable immunodeficiency, that may lead to altered CD4 T-cell counts that are recognized in later life (see Chap. 88).102,136 The pathogenesis of this disorder is not known, although one study found that the CD4+ T cells from patients with this abnormality were unusually sensitive to programmed cell death induced by T-cell–receptor cross-linking.137
Although some patients with idiopathic CD4+ T lymphocytopenia do not have any clinical manifestations,138,139 and 140 over half of all reported cases have had prior opportunistic infections indicative of a cellular immunodeficiency (e.g., recurrent herpes zoster, pulmonary Mycobacterium avium, Pneumocystis carinii pneumonia, or cryptococcal osteomyelitis).141,142,143,144 and 145 Patients who have such a clinical history are classified by the World Health Organization as having idiopathic CD4+ T lymphocytopenia and severe unexplained HIV-seronegative immune suppression.102
The exact proportion of patients with this disorder is unknown, since patients who are not affected clinically by the isolated CD4+ T-cell depletion may not come to medical attention. There are several reports of this abnormality in aged individuals, suggesting that the incidence may be increased in the aged population.143,146,147 CD4+ T-lymphocytopenic patients with this condition differ from those infected with HIV in that they generally have stable CD4+ counts over time and may manifest reductions in other lymphocyte subgroups.139,148 Also, patients with this abnormality may have a complete or partial spontaneous reversal in the CD4+ T lymphocytopenia.139
CHAPTER REFERENCES

1.
Chanarin I, Tidmarsh E, Harrisingh D, Skacel PO: Significance of lymphocytosis in adults. Lancet 2:897, 1984.

2.
Thommasen HV, Boyko WJ, Montaner JS, Russell JA, Johnson DR, Hogg JC: Absolute lymphocytosis associated with nonsurgical trauma. Am J Clin Pathol 86:480, 1986.

3.
Francis C, Connelly MC: Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood. Cytometry 25:58, 1996.

4.
Sun T, Sangaline R, Ryder J, et al: Gating strategy for immunophenotyping of leukemia and lymphoma. Am J Clin Pathol 108:152, 1997.

5.
Bellido M, Rubiol E, Ubeda J, et al: Rapid and simple immunophenotypic characterization of lymphocytes using a new test. Haematologica 83:681, 1998.

6.
Crotty PL, Smith BR, Tallini G: Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin’s lymphoma. Diagn Mol Pathol 7:90, 1998.

7.
Villas BH: Flow cytometry: An overview. Cell Vision 5:56, 1998.

8.
Schlenke P, Frohn C, Klüter H, et al: Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres. Cytometry 33:310, 1998.

9.
Wells DA, Sale GE, Shulman HM, et al: Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 110:84, 1998.

10.
Kutok JL, Roma AO, Lemire SJ, Dorfman DM: Four-color flow cytometric immunophenotypic determination of peripheral blood CD4+ T-lymphocyte counts: A comparison of validity and cost-effectiveness with a two-color method. Am J Clin Pathol 110:465, 1998.

11.
Weir EG, Cowan K, LeBeau P, Borowitz MJ: A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: Implications for residual disease detection. Leukemia 13:558, 1999.

12.
Rockman SP: Determination of clonality in patients who present with diagnostic dilemmas: A laboratory experience and review of the literature. Leukemia 11:852, 1997.

13.
Scott CS, Richards SJ, Sivakumaran M, et al: Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: The Yorkshire Leukaemia Group Study. Br J Haematol 83:505, 1993.

14.
de Pasquale A, Ginaldi L, di Leonardo G, Napoletano C, Quaglino D: Exercise-induced variations of lymphocytosis in the lymphoproliferative disease of large granular lymphocytes [letter]. Br J Haematol 82:178, 1992.

15.
Kimby E, Mellstedt H, Bjorkholm M, Holm G: Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance. Eur J Haematol 43:452, 1989.

16.
Garcia C, Rosen A, Kimby E, et al: Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS). Leuk Res 13:31, 1989.

17.
Aman P, Mellstedt H: The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population. Leuk Res 15:715, 1991.

18.
Bassan R, Amaru R, Rambaldi A, Ruggeri M, Borleri GM, Barbui T: The natural history of monoclonal villous lymphocytosis: A chronic lymphoproliferative disorder of CD11c+ B cells. Leuk Lymph 21:181, 1996.

19.
Ritis K, Tsironidou V, Martinis G, Kartalis G, Sideras P, Bourikas G: Development of CLL in individuals with mild lymphocytosis, without bone marrow infiltration, but with evidence of a monoclonally expanded population in peripheral blood. Haematologica 82:184, 1997.

20.
Delannoy A, Djian D, Wallef G, et al: Cigarette smoking and chronic polyclonal B-cell lymphocytosis. Nouv Rev Fr Hematol 35:141, 1993.

21.
Mossafa H, Malaure H, Maynadie M, et al: Persistent polyclonal B lymphocytosis with binucleated lymphocytes: A study of 25 cases. Groupe Français d’Hématologie Cellulaire. Br J Haematol 104:486, 1999.

22.
Delage R, Roy J, Jacques L, Bernier V, Delâge JM, Darveau A: Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosis. Br J Haematol 97:589, 1997.

23.
Chan MA, Benedict SH, Carstairs KC, Francombe WH, Gelfand EW: Expansion of B lymphocytes with an unusual immunoglobulin rearrangement associated with atypical lymphocytosis and cigarette smoking. Am J Respir Cell Mol Biol 2:549, 1990.

24.
Troussard X, Flandrin G: Chronic B-cell lymphocytosis with binucleated lymphocytes (LWBL): A review of 38 cases. Leuk Lymph 20:275, 1996.

25.
Chow KC, Nacilla JQ, Witzig TE, Li CY: Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridization. Am J Hematol 41:270, 1992.

26.
Mitterer M, Pescosta N, Fend F, et al: Chronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis. Br J Haematol 90:526, 1995.

27.
Larcher C, Fend F, Mitterer M, Prang N, Schwarzmann F, Huemer HP: Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis. Br J Haematol 90:532, 1995.

28.
Larcher C, McQuain C, Berger C, et al: Epstein-Barr virus–associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene. Ann Hematol 74:23, 1997.

29.
Carr R, Fishlock K, Matutes E: Persistent polyclonal B-cell lymphocytosis in identical twins. Br J Haematol 96:272, 1997.

30.
Machii T, Yamaguchi M, Inoue R, et al: Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant. Blood 89:2008, 1997.

31.
Lush CJ, Vora AJ, Campbell AC, Wood JK: Polyclonal CD5+ B-lymphocytosis resembling chronic lymphocytic leukaemia. Br J Haematol 79:119, 1991.

32.
Manteiga R, Munoz L, Nomdedéu JF: CD5/CD19/CD23 chronic lymphocytosis [letter]. Haematologica 82:510, 1997.

33.
Troussard X, Mossafa H, Valensi F, et al: [Polyclonal lymphocytosis with binucleated lymphocytes: Morphological, immunological, cytogenetic and molecular analysis in 15 cases]. Presse Med 26:895, 1997.

34.
Carstairs KC, Francombe WH, Scott JG, Gelfand EW: Persistent polyclonal lymphocytosis of B lymphocytes, induced by cigarette smoking? [letter]. Lancet 1:1094, 1985.

35.
Callet-Bauchu E, Renard N, Gazzo S, et al: Distribution of the cytogenetic abnormality +i(3)(q10) in persistent polyclonal B-cell lymphocytosis: A FICTION study in three cases. Br J Haematol 99:531, 1997.

36.
Granados E, Llamas P, Pinilla I, et al: Persistent polyclonal B lymphocytosis with multiple bcl-2/IgH rearrangements: A benign disorder. Haematologica 83:369, 1998.

37.
Delage R, Roy J, Jacques L, Darveau A: All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements. Leuk Lymph 31:567, 1998.

38.
Roy J, Ryckman C, Bernier V, Whittom R, Delage R: Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis. Leukemia 12:1026, 1998.

39.
Radossi P, Dazzi F, De Franchis G, et al: Myasthenic syndrome and oligoclonal lymphocytosis: Evolution into chronic lymphocytic leukemia. Ann Hematol 76:45, 1998.

40.
Brown KA: Nonmalignant disorders of lymphocytes. Clin Lab Sci 10:329, 1997.

41.
Horwitz MS, Moore GT: Acute infectious lymphocytosis: An etiologic and epidemilogic study of an outbreak. N Engl J Med 279:399, 1968.

42.
Scalletar HE, Maisel JE, Bramson M: Acute infectious lymphocytosis: Report of an outbreak. Am J Dis Child 88:15, 1954.

43.
Labalette M, Salez F, Pruvot FR, Noel C, Dessaint JP: CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: Expansion of an uncommon CD8+ CD57– subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol 95:465, 1994.

44.
Labalette M, Queyrel V, Masy E, Noel C, Pruvot FR, Dessaint JP: Implication of cyclosporine in up-regulation of Bcl-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipients. Transplantation 59:1714, 1995.

45.
Hertenstein B, Hampl W, Bunjes D, et al: In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant 15:387, 1995.

46.
Kunno A, Abe M, Yamada M, Murakami K: Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults. Liver 17:129, 1997.

47.
Arnez M, Cizman M, Jazbec J, Kotnik A: Acute infectious lymphocytosis caused by coxsackievirus B2. Pediatr Infect Dis J 15:1127, 1996.

48.
Sijpkens YW, de Knegt RJ, van der Werf SD: Unusual presentation of acquired toxoplasmosis in an immunocompetent adult. Netherlands J Med 45:174, 1994.

49.
Cunha BA, Bohoan JT, Schlossberg D: Atypical lymphocytes in acute malaria [letter]. Arch Intern Med 157:1140, 1997.

50.
Kubic VL, Kubic PT, Brunning RD: The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection. Am J Clin Pathol 95:809, 1991.

51.
De Martino M, Rossi ME, Muccioli AT, Ulivelli A, Vierucci A: Preferential increase of a T-cell subset as a cause of lymphocytosis in children with whooping cough. Boll Ist Sieroter Milan. 63:479, 1984.

52.
Person PL, Korngold R, Teuscher C: Pertussis toxin-induced lymphocytosis is associated with alterations in thymocyte subpopulations. J Immunol 148:1506, 1992.

53.
Verschueren H, Dewit J, Van der Wegen A, et al: The lymphocytosis promoting action of pertussis toxin can be mimicked in vitro: Holotoxin but not the B subunit inhibits invasion of human T lymphoma cells through fibroblast monolayers. J Immunol Methods 144:231, 1991.

54.
Passador L, Iglewski W: ADP-ribosylating toxins. Methods Enzymol 235:617, 1994.

55.
Burnette WN: AB5 ADP-ribosylating toxins: Comparative anatomy and physiology. Structure 2:151, 1994.

56.
Suzuki G, Sawa H, Kobayashi Y, et al: Pertussis toxin–sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. J Immunol 162:5981, 1999.

57.
Witvliet MH, Vogel ML, Wiertz EJ, Poolman JT: Interaction of pertussis toxin with human T lymphocytes. Infect Immun 60:5085, 1992.

58.
Pinkerton PH, McLellan BA, Quantz MC, Robinson JB: Acute lymphocytosis after trauma: Early recognition of the high-risk patient? J Trauma 29:749, 1989.

59.
Teggatz JR, Parkin J, Peterson L: Transient atypical lymphocytosis in patients with emergency medical conditions. Arch Pathol Lab Med 111:712, 1987.

60.
Toft P, Tonnesen E, Svendsen P, Rasmussen JW, Christensen NJ: The redistribution of lymphocytes during adrenaline infusion: An in vivo study with radiolabelled cells. APMIS 100:593, 1992.

61.
Tonnesen E, Hohndorf K, Lerbjerg G, Christensen NJ, Huttel MS, Andersen K: Immunological and hormonal responses to lung surgery during one-lung ventilation. Eur J Anaesthesiol 10:189, 1993.

62.
Mills PJ, Berry CC, Dimsdale JE, Ziegler MG, Nelesen RA, Kennedy BP: Lymphocyte subset redistribution in response to acute experimental stress: Effects of gender, ethnicity, hypertension, and the sympathetic nervous system. Brain Behav Immun 9:61, 1995.

63.
Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M: Catecholamine-induced leukocytosis: Early observations, current research, and future directions. Brain Behav Immun 10:77, 1996.

64.
Juneja S, Januszewicz E, Wolf M, Cooper I: Post-splenectomy lymphocytosis. Clin Lab Haematol 17:335, 1995.

65.
Domingo P, Fuster M, Muñiz-Diaz E, Ris J, Barrio JL: Spurious post-splenectomy CD4 and CD8 lymphocytosis in HIV-infected patients [letter]. AIDS 10:106, 1996.

66.
Saway PA, Prasthofer EF, Barton JC: Prevalence of granular lymphocyte proliferation in patients with rheumatoid arthritis and neutropenia. Am J Med 86:303, 1989.

67.
Stanworth SJ, Green L, Pumphrey RS, Swinson DR, Bhavnani M: An unusual association of Felty syndrome and TCR gamma delta lymphocytosis. J Clin Pathol 49:351, 1996.

68.
Grossi A, Nozzoli C, Gheri R, et al: Pure red cell aplasia in autoimmune polyglandular syndrome with T lymphocytosis [letter]. Haematologica 83:1043, 1998.

69.
Garcia-Suarez J, Prieto A, Reyes E, et al: Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br J Haematol 89:653, 1995.

70.
Tefferi A, Li CY, Phyliky RL: Role of immunotyping in chronic lymphocytosis: Review of the natural history of the condition in 145 adult patients. Mayo Clin Proc 63:801, 1988.

71.
Medeiros LJ, Bhagat SK, Naylor P, Fowler D, Jaffe ES, Stetler-Stevenson M: Malignant thymoma associated with T-cell lymphocytosis: A case report with immunophenotypic and gene rearrangement analysis. Arch Pathol Lab Med 117:279, 1993.

72.
Doll DC, Landreneau RJ, List AF: Malignant thymoma associated with peripheral T-cell lymphocytosis. Med Pediatr Oncol 19:496, 1991.

73.
Lishner M, Ravid M, Shapira J, et al: Delta-T-lymphocytosis in a patient with thymoma. Cancer 74:2924, 1994.

74.
Smith GP, Perkins SL, Segal GH, Kjeldsberg CR: T-cell lymphocytosis associated with invasive thymomas. Am J Clin Pathol 102:447, 1994.

75.
Cranney A, Markman S, Lach B, Karsh J: Polymyositis in a patient with thymoma and T cell lymphocytosis. J Rheumatol 24:1413, 1997.

76.
Rosenthal NS, Farhi DC: Reactive plasmacytosis and lymphocytosis in acute myeloid leukemia. Hematol Pathol 8:43, 1994.

77.
Quantz MC, Robinson JB, Sachs V, Pinkerton PH: Lymphocyte surface marker studies in the diagnosis of unexplained lymphocytosis. Can Med Assoc J 136:835, 1987.

78.
Inbal A, Avidor I, Nemesh L, Shaklai M: Persistent lymphocytosis: An unusual feature in sarcoidosis. Acta Haematol. 74:184, 1985.

79.
Tollerud DJ, Clark JW, Brown LM, et al: The effects of cigarette smoking on T cell subsets: A population-based survey of healthy caucasians. Am Rev Respir Dis 139:1446, 1989.

80.
Tokura Y, Tamura Y, Takigawa M, et al: Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 126:362, 1990.

81.
Sakai C, Takagi T, Oguro M, Tanabe N, Wakatsuki S: Erythroderma and marked atypical lymphocytosis mimicking cutaneous T-cell lymphoma probably caused by phenobarbital. Intern Med 32:182, 1993.

82.
Berliner N: T gamma lymphocytosis and T cell chronic leukemias. Hematol Oncol Clin North Am 4:473, 1990.

83.
Kimby E, Mellstedt H, Nilsson B, Bjorkholm M, Holm G: Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS). Leukemia 3:501, 1989.

84.
Perreault C, Boileau J, Gyger M, et al: Chronic B-cell lymphocytosis. Eur J Haematol 42:361, 1989.

85.
Itescu S: Diffuse infiltrative lymphocytosis syndrome in children and adults infected with A model of rheumatic illness caused by acquired viral infection. Am J Reprod Immunol 28:247, 1992.

86.
Itescu S, Brancato LJ, Buxbaum J, et al: A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: A host immune response associated with HLA-DR5. Ann Intern Med 112:3, 1990.

87.
Zambello R, Trentin L, Agostini C, et al: Persistent polyclonal lymphocytosis in human immunodeficiency virus-1-infected patients. Blood 81:3015, 1993.

88.
Itescu S, Dalton J, Zhang HZ, Winchester R: Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. J Clin Invest 91:2216, 1993.

89.
Bachmeyer C, Dhôte R, Blanche P, Tulliez M, Sicard D, Christoforov B: Diffuse infiltrative CD8 lymphocytosis syndrome with predominant neurologic manifestations in two HIV-infected patients responding to zidovudine [letter]. AIDS 9:1101, 1995.

90.
Scharko AM, Graziano FM, Malkovsky M, Pauza CD, Wallace M: Persistent non-B cell lymphocytosis in HIV-infected individuals [letter]. Immunol Lett 48:157, 1995.

91.
Kazi S, Cohen PR, Williams F, Schempp R, Reveille JD: The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 10:385, 1996.

92.
Williams FM, Cohen PR, Jumshyd J, Reveille JD: Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum 41:863, 1998.

93.
Smith JG, Smith MA, James I, Blundell E, Maddison PJ: Inhibition of CFU-GM by prostaglandins in a case of chronic T-cell lymphocytosis and neutropenia. Br J Haematol 73:148, 1989.

94.
Tollerud DJ, Brown LM, Blattner WA, Mann DL, Pankiw-Trost L, Hoover RN: T cell subsets in healthy black smokers and nonsmokers: Evidence for ethnic group as an important response modifier. Am Rev Respir Dis 144:612, 1991.

95.
Wilkinson LS, Tang A, Gjedsted A: Marked lymphocytosis suggesting chronic lymphocytic leukemia in three patients with hyposplenism. Am J Med 75:1053, 1983.

96.
Landmann RM, Muller FB, Perini C, Wesp M, Erne P, Buhler FR: Changes of immunoregulatory cells induced by psychological and physical stress: Relationship to plasma catecholamines. Clin Exp Immunol 58:127, 1984.

97.
Tiberghien P, Racadot E, Deschaseaux ML, et al: Interleukin-2-induced increase of a monoclonal B-cell lymphocytosis: A novel in vivo interleukin-2 effect? Cancer 69:2583, 1992.

98.
Higa K, Hirata K, Dan K: Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction. Pain 73:97, 1997.

99.
Groom DA, Kunkel LA, Brynes RK, Parker JW, Johnson CS, Endres D: Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions: An immunophenotyping study. Arch Pathol Lab Med 114:570, 1990.

100.
Miale JB: Laboratory Medicine, vol 15, Hematology, 6th ed. Mosby, St Louis, 1982.

101.
Hancock BW, Dunsmore IR, Swan HT: Lymphopenia: A bad prognostic factor in Hodgkin’s disease. Scand J Haematol 29:193, 1982.

102.
Laurence J: T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann Intern Med 119:55, 1993.

103.
Castelino DJ, McNair P, Kay TW: Lymphocytopenia in a hospital population: What does it signify? Aust NZ J Med 27:170, 1997.

104.
Molina IJ, Kenney DM, Rosen FS, Remold-O’Donnell E: T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 176:867, 1992.

105.
Phillips AN: CD4 lymphocyte depletion prior to the development of AIDS [editorial]. AIDS 6:735, 1992.

106.
Maury CP, Lahdevirta J: Correlation of serum cytokine levels with haematological abnormalities in human immunodeficiency virus infection. J Intern Med 227:253, 1990.

107.
Stricker K, Knipping E, Böhler T, Benner A, Krammer PH, Debatin KM: Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children. Cell Death Differ 5:222, 1998.

108.
Jaworowski A, Crowe SM: Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis? Immunol Cell Biol 77:90, 1999.

109.
Daniel V, Melk A, Süsal C, et al: CD4 depletion in HIV-infected haemophilia patients is associated with rapid clearance of immune complex-coated CD4+ lymphocytes. Clin Exp Immunol 115:477, 1999.

110.
Pilheu JA, De Salvo MC, Gonzalez J, Rey D, Elias MC, Ruppi MC: CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection. Int J Tuberc Lung Dis 1:422, 1997.

111.
Van Campen H, Easterday BC, Hinshaw VS: Destruction of lymphocytes by a virulent avian influenza A virus. J Gen Virol 70:467, 1989.

112.
Bast RCJ, Reinherz EL, Maver C, Lavin P, Schlossman SF: Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. Clin Immunol Immunopathol 28:101, 1983.

113.
Petrini B, Wasserman J, Rotstein S, Blomgren H: Radiotherapy and persistent reduction of peripheral T cells. J Clin Lab Immunol 11:159, 1983.

114.
Calabresi P, Chabner BA: Chemotherapy of neoplastic diseases, in The Pharmacological Basis of Therapeutics, 8th ed, edited by AG Gilman, TW Rall, AS Nies, P Taylor, p 1202. Pergamon, New York, 1990.

115.
Handschumacher RE: Immunosuppressive agents, in The Pharmacological Basis of Therapeutics, 8th ed, edited by AG Gilman, TW Rall, AS Nies, P Taylor, p 1264. Pergamon, New York, 1990.

116.
de Planque MM, Brand A, Kluin-Nelemans HC, et al: Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti-thymocyte globulin. Br J Haematol 71:421, 1989.

117.
Borroni G, Zaccone C, Vignati G, et al: Lymphopenia and decrease in the total number of circulating CD3+ and CD4+ T cells during “long-term” PUVA treatment for psoriasis. Dermatologica 183:10, 1991.

118.
Bloemena E, Weinreich S, Schellekens PT: The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo. Clin Exp Immunol 80:460, 1990.

119.
Bloemena E, Koopmans RP, Weinreich S, Van Boxtel CJ, Schellekens PT: Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals. Clin Immunol Immunopathol 57:374, 1990.

120.
Braat MC, Oosterhuis B, Koopmans RP, Meewis JM, Van Boxtel CJ: Kinetic-dynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone. J Pharmacol Exp Ther 262:509, 1992.

121.
Jakobsen BW, Pedersen J, Egeberg BB: Postoperative lymphocytopenia and leucocytosis after epidural and general anaesthesia. Acta Anaesthesiol Scand 30:668, 1986.

122.
Platt MP, Lovat PE, Watson JG, Aynsley-Green A: The effects of anesthesia and surgery on lymphocyte populations and function in infants and children. J Pediatr Surg 24:884, 1989.

123.
Hauser GJ, Chan MM, Casey WF, Midgley FM, Holbrook PR: Immune dysfunction in children after corrective surgery for congenital heart disease. Crit Care Med 19:874, 1991.

124.
Ueo T, Tanaka S, Tominaga Y, Ogawa H, Sakurami T: The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis. Arthritis Rheum 22:1405, 1979.

125.
Prior CR, Coghlan PJ, Hall JM, Jacobs P: In vitro study of immunologic changes in long-term cytapheresis donors. J Clin Apheresis 6:69, 1991.

126.
Martin-Suarez I, D’Cruz D, Mansoor M, Fernandes AP, Khamashta MA, Hughes GR: Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis 56:481, 1997.

127.
Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M: A model for disease heterogeneity in systemic lupus erythematosus: Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 32:826, 1989.

128.
Noguchi M, Iwamori M, Hirano T, et al: Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia. Ann Rheum Dis 51:713, 1992.

129.
Daniele RP, Dauber JH, Rossman MD: Immunologic abnormalities in sarcoidosis. Ann Intern Med 92:406, 1980.

130.
Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93:597, 1980.

131.
Perrick D, Guill MF, Clark J: Chronic abdominal pain, lymphopenia, and hypogammaglobulinemia in a 9-year-old female. Ann Allergy 62:287, 1989.

132.
Maldonado MD, Venturoli A, Franco A, Nunez-Roldan A: Specific changes in peripheral blood lymphocyte phenotype from burn patients: Probable origin of the thermal injury-related lymphocytopenia. Burns 17:188, 1991.

133.
Prasad AS: Discovery and importance of zinc in human nutrition. Fed Proc 43:2829, 1984.

134.
Tonnesen H, Andersen JR, Pedersen AE, Kaiser AH: Lymphopenia in heavy drinkers: Reversibility and relation to the duration of drinking episodes. Ann Med 22:229, 1990.

135.
Smith DK, Neal JJ, Holmberg SD: Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 328:373, 1993.

136.
al-Attas RA, Rahi AH, Ahmed el FE: Common variable immunodeficiency with CD4+ T lymphocytopenia and overproduction of soluble IL-2 receptor associated with Turner’s syndrome and dorsal kyphoscoliosis. J Clin Pathol 50:876, 1997.

137.
Laurence J, Mitra D, Steiner M, Lynch DH, Siegal FP, Staiano-Coico L: Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest 97:672, 1996.

138.
Spira TJ, Jones BM, Nicholson JK, et al: Idiopathic CD4+ T-lymphocytopenia: An analysis of five patients with unexplained opportunistic infections. N Engl J Med 328:386, 1993.

139.
Ho DD, Cao Y, Zhu T, et al: Idiopathic CD4+ T-lymphocytopenia: Immunodeficiency without evidence of HIV infection. N Engl J Med 328:380, 1993.

140.
Cascio G, Massobrio AM, Cascio B, Anania A: Undefined CD4 lymphocytopenia without clinical complications: A report of two cases. Panminerva Med 40:69, 1998.

141.
Sinicco A, Maiello A, Raiteri R, et al: Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax 51:446, 1996.

142.
Manchado Lopez P, Ruiz de Morales JM, Ruiz González I, Rodriguez Prieto MA: Cutaneous infections by papillomavirus, herpes zoster and Candida albicans as the only manifestation of idiopathic CD4+ T lymphocytopenia. Int J Dermatol 38:119, 1999.

143.
Matsuyama W, Tsurukawa T, Iwami F, et al: Two cases of idiopathic CD4+ T-lymphocytopenia in elderly patients. Intern Med 37:891, 1998.

144.
Ishida T, Hashimoto T, Arita M, Ito I, Osawa M: Pulmonary Mycobacterium avium disease in a young patient with idiopathic CD4+ T lymphocytopenia. Intern Med 37:622, 1998.

145.
Kumlin U, Elmqvist LG, Granlund M, Olsen B, Tärnvik A: CD4 lymphopenia in a patient with cryptococcal osteomyelitis. Scand J Infect Dis 29:205, 1997.

146.
Belmin J, Ortega MN, Bruhat A, Mercadier A, Valensi P: CD4 lymphopenia in very elderly people [letter]. Lancet 347:328, 1996.

147.
McBride M: CD4 lymphopenia in elderly patients [letter, comment]. Lancet 347:911, 1996.

148.
Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM: Idiopathic CD4+ T-lymphocytopenia: Four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 328:393, 1993.

149.
Gelfand EW, Dosch HM: Diagnosis and classification of severe combined immunodeficiency disease. Birth Defects 19:65, 1983.

150.
Parkman R, Gelfand EW, Rosen FS, Sanderson A, Hirschhorn R: Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med 292:714, 1975.

151.
Touraine JL, Betuel H, Souillet G, Jeune M: Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens. J Pediatr 93:47, 1978.

152.
Edwards KM, Cooper MD, Lawton AR, Sanders DS, Wright PF: Severe combined immunodeficiency associated with absent T4+ helper cells. J Pediatr 105:70, 1984.

153.
Freier S, Kerem E, Dranitzki Z, et al: Hereditary CD4+ T lymphocytopenia. Arch Dis Child 78:371, 1998.

154.
Gitlin D, Vawter G, Craig JM: Thymic alymphoplasia and congenital aleukocytosis. Pediatrics 33:184, 1964.

155.
Datta U, Sehgal S, Kumar L, et al: Immune status in ataxia telangiectasia. Indian J Med Res 94:252, 1991.

156.
Cooper MD, Chae HP, Lowman JT, Krivit W, Good RA: Wiskott-Aldrich syndrome: An immunologic deficiency disease involving the afferent limb of immunity. Am J Med 44:499, 1968.

157.
Lux SE, Johnston RBJ, August CS, et al: Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 282:231, 1970.

158.
Pierce GF, Polmar SH: Lymphocyte dysfunction in cartilage hair hypoplasia: II. Evidence for a cell cycle specific defect in T cell growth. Clin Exp Immunol 50:621, 1982.

159.
Korn D, Gelderman A, Cage G, Nathanson D, Strauss AJ: Immune deficiencies, aplastic anemia and abnormalities of lymphoid tissue in thymoma. N Engl J Med 276:1333, 1967.

160.
Rich KC, Arnold WJ, Palella T, Fox IH: Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency. Am J Med 67:172, 1979.

161.
Etzioni A, Benderly A, Rosenthal E, et al: Defective humoral and cellular immune functions associated with veno-occlusive disease of the liver. J Pediatr 110:549, 1987.

162.
Sabbe LJ, Haak HL, Te Velde J, et al: Immunological investigations in aplastic anemia patients. Acta Haematol 71:178, 1984.

163.
Mazzucchelli I, Vezzoli M, Ottini E, Paulli M, Boveri E, Mazzone A: A complex immunodeficiency: Idiopathic CD4+ T-lymphocytopenia and hypogammaglobulinemia associated with HHV8 infection, Kaposi’s sarcoma and gastric cancer [letter]. Haematologica 84:378, 1999.

164.
García-Silva J, Almagro M, Peña C, et al: CD4+ T-lymphocytopenia, Kaposi’s sarcoma, HHV-8 infection, severe seborrheic dermatitis, and onychomycosis in a homosexual man without HIV infection [letter]. Int J Dermatol 38:231, 1999.

165.
Iwase T, Ojika K, Katada E, et al: An unusual course of progressive multifocal leukoencephalopathy in a patient with idiopathic CD+ T lymphocytopenia. J Neurol Neurosurg Psychiatry 64:788, 1998.

166.
Abdool Gaffar MS, Seedat YK, Coovadia YM, Khan Q: The white cell count in typhoid fever. Trop Geogr Med 44:23, 1992.

167.
Ducloux D, Carron PL, Racadot E, et al: CD4 lymphocytopenia in long-term renal transplant recipients. Transplant Proc 30:2859, 1998.

168.
Symmons DP, Farr M, Salmon M, Bacon PA: Lymphopenia in rheumatoid arthritis. J R Soc Med 82:462, 1989.

169.
Davis S, Schumacher MJ: Myasthenia gravis and lymphoma: A clinical and immunological association. JAMA 242:2096, 1979.

170.
Bordin G, Ballaré M, Paglino S, et al: Idiopathic CD4+ lymphocytopenia and systemic vasculitis. J Intern Med 240:37, 1996.

171.
Venzor J, Hua Q, Bressler RB, Miranda CH, Huston DP: Behçet’s-like syndrome associated with idiopathic CD4+ T-lymphocytopenia, opportunistic infections, and a large population of TCR alpha beta+ CD4– CD8– T cells. Am J Med Sci 313:236, 1997.

172.
Rijnders RJ, van den Ende IE, Huikeshoven FJ: Suspected idiopathic CD4+ T-lymphocytopenia in a young patient with vulvar carcinoma stage IV. Gynecol Oncol 61:423, 1996.
Books@Ovid
Copyright © 2001 McGraw-Hill
Ernest Beutler, Marshall A. Lichtman, Barry S. Coller, Thomas J. Kipps, and Uri Seligsohn
Williams Hematology

About these ads

3 comments on “CHAPTER 87 LYMPHOCYTOSIS AND LYMPHOCYTOPENIA

  1. Sweet site , super pattern , rattling clean and use friendly . 9024

  2. hcegfdsws tklmg knbmuyi ertr gihcwqymtdjrbwq

  3. Now it is a web-site. Really like this data wound dressing

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 371 other followers

%d bloggers like this: